These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 1680982)

  • 21. Enalapril decreases prevalence of ventricular tachycardia in patients with chronic congestive heart failure. The V-HeFT II VA Cooperative Studies Group.
    Fletcher RD; Cintron GB; Johnson G; Orndorff J; Carson P; Cohn JN
    Circulation; 1993 Jun; 87(6 Suppl):VI49-55. PubMed ID: 8500239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of enalapril versus digoxin for congestive heart failure.
    Beaune J
    Am J Cardiol; 1989 Feb; 63(8):22D-25D. PubMed ID: 2537562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renin-Angiotensin-Aldosterone Signaling Inhibitors-Losartan, Enalapril, and Cardosten-Prevent Infarction-induced Heart Failure Development in Rats.
    Kiss K; Fekete V; Pálóczi J; Sárközy M; Murlasits Z; Pipis J; Kheyfets IA; Dugina JL; Sergeeva SA; Epstein OI; Csonka C; Csont T; Ferdinandy P; Bencsik P
    Altern Ther Health Med; 2016; 22(2):10-7. PubMed ID: 27036051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydralazine and isosorbide dinitrate combination improves exercise tolerance in heart failure. Results from V-HeFT I and V-HeFT II. The V-HeFT VA Cooperative Studies Group.
    Ziesche S; Cobb FR; Cohn JN; Johnson G; Tristani F
    Circulation; 1993 Jun; 87(6 Suppl):VI56-64. PubMed ID: 8500241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors.
    Sigurdsson A
    Blood Press Suppl; 1995; 1():1-45. PubMed ID: 7599749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enalapril. An update of its pharmacological properties and therapeutic use in congestive heart failure.
    Todd PA; Goa KL
    Drugs; 1989 Feb; 37(2):141-61. PubMed ID: 2539290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-dose enalapril in severe chronic heart failure.
    Brilla CG; Krämer B; Hoffmeister HM; Müller-Schauenburg W; Risler T; Seipel L
    Cardiovasc Drugs Ther; 1989 Apr; 3(2):211-8. PubMed ID: 2562137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The role of ACE inhibitors in heart failure. Lessons of CONSENSUS, SOLVD and V-HeFTII].
    Dessì-Fulgheri P; Paci MV; Rappelli A
    Ann Ital Med Int; 1994 Oct; 9 Suppl():16S-18S. PubMed ID: 7857751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of enalapril and neuroendocrine activation on prognosis in severe congestive heart failure (follow-up of the CONSENSUS trial). CONSENSUS Trial Study Group.
    Swedberg K; Eneroth P; Kjekshus J; Snapinn S
    Am J Cardiol; 1990 Oct; 66(11):40D-44D; discussion 44D-45D. PubMed ID: 2220604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tolerability of enalapril in congestive heart failure.
    Kjekshus J; Swedberg K
    Am J Cardiol; 1988 Jul; 62(2):67A-72A. PubMed ID: 2839020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal toxicity of enalapril in very elderly patients with progressive, severe congestive heart failure.
    Schwartz D; Averbuch M; Pines A; Kornowski R; Levo Y
    Chest; 1991 Dec; 100(6):1558-61. PubMed ID: 1959395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic interventions to reduce rates of hospitalization and death in patients with heart failure: new clinical evidence.
    Coats AJ
    Cardiology; 1992; 81(1):1-7. PubMed ID: 1477852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of ACE-inhibition on renal function in severe congestive heart failure.
    Swedberg K
    Z Kardiol; 1991; 80 Suppl 2():50-4. PubMed ID: 2024543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Costs and effectiveness of angiotensin converting enzyme inhibition in patients with congestive heart failure.
    Paul SD; Kuntz KM; Eagle KA; Weinstein MC
    Arch Intern Med; 1994 May; 154(10):1143-9. PubMed ID: 8185426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Efficacy of long-term treatment with enalapril in patients with congestive heart failure].
    Cannavà G; Buttafarro A; Mangano A; Silipigni C; Cordiani A; Casella F; Pavia L
    Cardiologia; 1990 Jun; 35(6):485-7. PubMed ID: 2127733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).
    Swedberg K; Kjekshus J
    Am J Cardiol; 1988 Jul; 62(2):60A-66A. PubMed ID: 2839019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute haemodynamic, hormonal and electrolyte effects and short-term clinical response to enalapril in heart failure.
    Fitzpatrick D; Nicholls MG; Ikram H; Espiner EA
    J Hypertens Suppl; 1983 Oct; 1(1):147-53. PubMed ID: 6100604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic advances in heart failure.
    Meinertz T; Drexler H; Just H
    Cardiovasc Drugs Ther; 1988 Nov; 2(Suppl 1):413-418. PubMed ID: 27722847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Neurohumoral activation, regulation of sodium excretion and vasodilator treatment in heart insufficiency].
    Pimenta J; Pereira M; Castro A; Dias P; Azevedo A; Bettencourt P; Ferreira A
    Rev Port Cardiol; 2002 Feb; 21(2):157-62. PubMed ID: 11963285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparison of enalapril and captopril in the treatment of chronic heart failure].
    Tjon-A-Meeuw L; Hess OM; Greminger P; Maire R; Jenni R; Krayenbuehl HP
    Z Kardiol; 1990 Jun; 79(6):429-35. PubMed ID: 2198731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.